Hasil Pencarian  ::  Simpan CSV :: Kembali

"Cepatnya penyebaran Virus Covid-19 menyebabkan Indonesia mengalami Kedaruratan Kesehatan Masyarakat. Oleh karena itu, untuk melindungi masyarakat Indonesia, Pemerintah Indonesia melakukan pengadaan Vaksin Covid-19 dan pelaksanaan Vaksinasi Program. Dalam pendistribusian Vaksin Covid-19, wajib memenuhi standar dan/atau persyaratan: (1) Keamanan (safety); (2) Mutu (quality); dan (3) Khasiat (efficacy)/imunogenisitas. Bentuk penelitian yang digunakan dalam penelitian adalah metode penelitian yuridis normatif dengan tipe deskriptif. Penulis mengkaji norma hukum tertulis, yaitu Pedoman Teknis CDOB sebagaimana yang diatur dalam PerBPOM 6/2020, Perpres 99/2020 beserta perubahannya, dan peraturan pelaksana Perpres 99/2020, yaitu: (1) PerMenkes 10/2021 beserta perubahannya; (2) PerMenkes 16/2021; dan (3) Juknis Vaksinasi Covid-19. Dari norma hukum di atas, Penulis menjelaskan mengenai prosedur pendistribusian Vaksin Covid-19 pada Vaksinasi Program dan menganalisis tanggung jawab Pemerintah Indonesia dalam pendistribusian Vaksin Covid-19 pada Vaksinasi Program mulai dari perencanaan sampai dengan Vaksin Covid-19 tersebut digunakan oleh masyarakat.

---

The rapid spread of the Covid-19 Virus has caused Indonesia to experience a Public Health Emergency. Therefore, to protect the Indonesian people, the Indonesian Government has procured a Covid-19 Vaccine and implemented a Vaccination Program. In distributing the Covid-19 Vaccine, it is obligatory to meet the following standards and or requirements: (1) Safety, (2) Quality, and (3) efficacy/immunogenicity. The form of research used in this research is a normative juridical research method with a descriptive type. The author examines written legal norms, namely the Good Distribution Practices Technical Guidelines as regulated in Regulation of the Food and Drugs Supervisory Agency Number 6 of 2020, Regulation of The President Number 99 of 2020 and their amendments, and implementing regulations for Regulation of The President Number 99 of 2020, namely (1) Regulation of The Minister of Health Number 10 of 2021 and its amendments, (2) Regulation of The Minister of Health Number 16 of 2021, and (3) Covid-19 Technical Guidelines. From the legal norms above, the author explains the procedure for distributing the Covid-19 Vaccine in the Vaccination Program and analyzes the responsibility of the Indonesian Government in distributing the Covid-19 Vaccine in the Vaccination Program from planning to the Covid-19 Vaccine used by the community."

"ABSTRAKNama : Dwi MeilaniProgram Studi : Magister Ilmu Kesehatan MasyarakatJudul Tesis : Analisis Perilaku Penolakan Vaksinasi Pada KomunitasAnti Vaksin di Media Sosial Facebook di Indonesia Tahun2016xvi 132 halaman, 6 tabel, 10 gambar, 4 lampiranMenurunnya cakupan vaksinasi di Indonesia diantaranya disebabkan oleh adanyakelompok yang menolak vaksinasi Kemkes, 2014 . Belum banyak penellitiantentang penolakan vaksin pada komunitas media sosial, karenanya penelitian inidilakukan pada dua komunitas anti vaksin di facebook group. Dengan tujuanmengetahui faktor determinan perilaku penolakan vaksin untuk dapat dijadikandasar merumuskan strategi program yang efektif. Penelitian menggunakanmetode kualitatif dan teori Health Belief Model. Hasil penelitian menemukandeterminan sosio demography yang membentuk persepsi informan terhadapvaksin dan risiko penyakit serta faktor penghambat dan faktor pencetus yangmendorong perilaku penolakan vaksin. Peneliti menyarankan kepada KementerianKesehatan untuk meningkatkan kampanye vaksinasi melalui media termasukmedia sosial, melakukan riset berkelanjutan untuk pengembangan vaksin, bagitenaga kesehatan untuk meningkatkan pengetahuan dan keterampilan terkaitvaksin dan teknik komunikasi efektif.Kata Kunci : Perilaku, Penolakan Vaksin, Health Belief Model, Anti Vaksin,Media Sosial

---

ABSTRACTName Dwi MeilaniStudy Program Public Health ScienceTitle Vaccination Refusal Behavior Analysis On Anti VaccinesCommunities on Social Media Facebook In Indonesia 2016xvi 132 pages, 6 tables, 10 pictures, 4 attachmentsOne of the causes of declining vaccination coverage in Indonesia is the group thatrefused immunization MoH, 2014 . Not many studies on vaccine refusal onsocial media community that has been done, so this study was conducted on twoanti vaccine communities on facebook group. With the aim of knowing thedeterminant factor rejection behavior of vaccines, that can be used as a basis toformulate an effective program strategies. Research using qualitative methodsand theoretical Health Belief Model. The results of the study found, thedeterminants of socio demography that shape perceptions of informants to thevaccine and the risk of disease and inhibiting factors and precipitating factors thatdrive behavior vaccine refusal. Researchers suggested to the Ministry of Health toincrease the vaccination campaign through the media, including social media,conduct ongoing research on vaccine development, for health personnel toimprove their knowledge and skills related to vaccines and effectivecommunication techniques.Keywords Behavior, Vaccine Refusal, Health Belief Model, Anti vaccine.Social Media"

"This volume is focused on the development of vaccines which generate immune effectors capable of blocking mucosal entry or peripheral pathogen spread. Other chapters describe strategies for enhancing uptake of mucosal vaccines, for instance through targeted delivery to antigen-sampling M cells, construction of virus-like particles which mimic natural pathogens, addition of mucoadhesives or formulation as nanoparticles. Topics include edible vaccines as well as plant-based production of subunit or particulate vaccines that could be administered by any route. Dry powder vaccines that could be insufflated or directly applied to mucosal surfaces may be particularly ideal for mass vaccination in developing countries. The manufacture, stability and efficacy of powder formulations is comprehensively reviewed. We conclude with chapters on two of the greatest challenges facing mucosal vaccine development : human immunodeficiency virus and bioterrorist agents. This monograph highlights progress and information that should prove invaluable for the development of contemporary vaccines that prevent infection by these and other mucosal pathogens."

"ABSTRAKLatar Belakang: Influenza masih merupakan ancaman infeksi serius di dunia terutama pada populasi usia lanjut. Meskipun kejadian influenza dapat ditekan dengan pemberian vaksinasi, namun efikasi vaksin influenza masih diragukan pada usia lanjut, terutama individu yang frail. Hal ini dikarenakan immunosenescence yang menyebabkan sistem imun kurang mampu mengatasi stres berupa infeksi termasuk memberikan respon yang adekuat terhadap pemberian vaksin.Tujuan: Mengetahui hubungan status frailty dengan respon imun pasca vaksinasi influenza pada populasi usia lanjutMetode: Studi kohort retrospektif ini mengambil data dari penelitian induk dengan subjek usia lanjut berusia 60 tahun keatas yang tergabung dalam Posyandu Lansia di 4 kelurahan di Kecamatan Pulo Gadung, Jakarta Timur. Status frailty ditentukan berdasarkan kuisoner Frailty Index 40 Items FI-40 . Vaksin Influenza yang dievaluasi adalah vaksin influenza trivalen inaktif. Serokonversi didefinisikan sebagai peningkatan titer inhibisi hemagglutinin sebanyak 4x lipat. Seroproteksi didefinisikan sebagai titer inhibisi hemagglutinin ge; 1:40.Hasil: Terdapat 140 subjek penelitian. Tingkat serokonversi vaksin influenza pada kelompok frail, pre-frail, dan sehat adalah 37,9 , 39 , 60 . Tingkat seroproteksi vaksin influenza pada kelompok frail, pre-frail dan sehat adalah 80 , 92,2 , 94,8 . Risiko relatif RR kelompok pre-frail/frail untuk kejadian tidak serokonversi adalah 0,93 IK 95 0,72-1,02 , dan RR untuk kejadian tidak seroproteksi adalah 1,7x IK 95 0,5-6,2 .Kesimpulan: Tidak ditemukan hubungan bermakna secara statistik antara status frailty dengan serokonversi dan seroproteksi vaksin influenza pada populasi usia lanjut.

---

ABSTRACT Background Influenza still become serious illness in this world especially in elderly population. Despite the prevalence of this disease has been decreased by vaccination, the efficacy of the vaccine still doubt full in frail elderly people. Immunosenescence is the underlying process in immune defect and cause the immune system become less capable to cope the stress like an infection, and also give an adequate response to vaccination.Objective To determine association between frailty status and immune response after influenza vaccination in elderly.Method This Retrospective cohort study was conducted using secondary data from the parent study of elderly subjects age ge 60 years who live in the community of Posyandu lansia in Pulo Gadung Region, East Jakarta. Frailty status was stated by Frailty Index 40 Items FI 40 . The influenza vaccine evaluated was the Trivalent Inactivated Vaccine. Seroconversion defined as four fold increase hemagglutinin inhibition titre. Seroprotection defined as Hemagglutinin Inhibition titer ge 1 40.Result There are 140 subject included in this study. Seroconversion influenza vaccine rate in frail, pre frail, and robust group are 37,9 , 39 , 60 . Seroprotection rate in frail, pre frail, and robust group are 80 , 92,2 , 94,8 . Relative Risk RR pre frail frail group for not seroconverted is 0,93 CI 95 0,72 1,02 , and RR for not seroprotected is 1,7 CI 95 0,5 6,2 .Conclussions There is no statistically significant association between frailty status and seroconversion nor seroprotection of influenza vaccine. "